Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1993-09-17
1995-10-31
Azpuru, Carlos A.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424DIG15, 514774, 514781, 514785, 514964, A61F 902, A61K 4738
Patent
active
054627400
ABSTRACT:
This invention provides a rectally administered composition for inhibiting epileptic seizure and to its methods of use. The composition contains, in a suitable solvent, an anti-epileptic agent for inhibiting epileptic seizure, a buffer for maintaining pH, and a thickener for imparting a viscosity to the composition effective for rectal administration by injection to a patient in epileptic seizure.
REFERENCES:
patent: 3244173 (1966-04-01), Berg
patent: 3958011 (1976-05-01), Pigerol et al.
patent: 3968230 (1976-07-01), Wright et al.
patent: 3988472 (1976-10-01), Pigerol et al.
patent: 4126672 (1978-11-01), Sheth et al.
patent: 4260755 (1981-04-01), Moran et al.
patent: 4322440 (1982-03-01), Fish et al.
patent: 4339447 (1982-07-01), Boguth et al.
patent: 4411894 (1983-10-01), Schrank et al.
patent: 4421745 (1983-12-01), Inanaga et al.
patent: 4758234 (1988-07-01), Orentreich et al.
patent: 4820278 (1989-04-01), Balisky
patent: 5095015 (1992-03-01), Albaugh
patent: 5112856 (1992-05-01), Gaginella et al.
patent: 5122598 (1992-06-01), Della Valle et al.
patent: 5130430 (1992-07-01), Shaw
patent: 5143731 (1992-09-01), Viegas et al.
patent: 5185408 (1993-02-01), Tang et al.
patent: 5195526 (1993-03-01), Michelson
patent: 5338312 (1994-08-01), Montgomery
Remington's Pharmaceutical Sciences, Mack Publishing Co., Ch. 56, pp. 1057-1066 and pp. 1072-1081, 18th ed., 1990.
The Medical Letter, vol. 31, Issue 783, 1-4, 1989.
Local Discomfort and Thrombophlebitis Following Intravenous Injection of Diazepam, A Comparison Between a Glycoferol-Water Solution and a Lipid Emulsion, D. Selander et al., Acta Anaesth. Scand., 25, 516-518 (1981).
The Lancet, Mar. 2, 1985, pp. 518-519.
The Anticonvulsive Activity and Toxicity of Diazepam in Three Different Formulations. An Experimental Study in Mice, S. Hogskilde et al., Acta Anaesthesiol Scand 1987:31 pp. 289-291.
A Preliminary Investigation into the Formulation and Dissolution of Diazepam Suppositories, Susan Hughes et al, Aust. J. Hosp. Pharm. vol. 14, No. 2, 1984.
Diazepam Adsorption to Infusion Sets and Plastic Syringes, M. Winsnes, R. Jeppsson and B. Sjoberg, Acta Anaesth. Scand. 1981, 25, pp. 93-96.
A Double-Blind Comparative Study of Three Formulations of Diazepam in Volunteers, P. Forrest and D. C. Galletly, Anaesth Intens Care (1988), 16, pp. 158-163.
Evenstad Kenneth L.
Gorham Thomas R.
O'Neill Victoria A.
Athena Neurosciences, Inc.
Azpuru Carlos A.
LandOfFree
Rectally-administered, epileptic-seizure-inhibiting composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rectally-administered, epileptic-seizure-inhibiting composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rectally-administered, epileptic-seizure-inhibiting composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1770655